Numan logo

Numan

Startups icon Seedtable Score 46 Startups icon Startups

2

Founding Rounds

2

Investors

$52.97m

Money raised

Overview

Numan, based in London, addresses the widespread health issue of erectile dysfunction (ED) with a direct-to-consumer model. Offering a personalized approach, it stands out compared to traditional doctor visits or over-the-counter medications. By focusing on ED, Numan aims to alleviate personal distress, relationship issues, and potential health complications. Supported by investors like Anthemis and VNV Global, the startup is well-positioned to tap into a niche market with high demand and limited specialized options.

Investors (2)

Anthemis logo Anthemis

Health Tech, Edtech, FinTech, Crypto & web3, Agritech, ...

Details
VNV Global logo VNV Global

Climate Tech & Green Tech, Health Tech, Edtech, FinTech, Foodtech, ...

Details

View all investors.

Join 23,000+ founders, operators and investors.

Fonding

Fonding series

Funding Series Analysis

The company Numan has raised a total of $52.97m in funding over 2 rounds.

Key Insights:

  • Series B: $40m
  • Series A: $12.97m
Numan logo
Numan Series A (2020, $12M) $12.97m
Numan logo
Numan Series B (2021, $40M) $40m